Cite
HARVARD Citation
Stege, C. et al. (2021). Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study. Journal of clinical oncology. 39 (25), pp. 2758-2767. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Stege, C. et al. (2021). Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study. Journal of clinical oncology. 39 (25), pp. 2758-2767. [Online].